Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL.

about

Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL.

Item

http://www.wikidata.org/entity/Q42371492

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@en

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@nl

type

Item

label

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@en

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@nl

prefLabel

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@en

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@nl

P1476

Lyn mediates FIP1L1-PDGFRA sig ...... yn/Akt network complex in CEL.

@en

P2093

Bin Li

http://www.w3.org/2001/XMLSchema#string

Chaojun Duan

http://www.w3.org/2001/XMLSchema#string

Chunfang Zhang

http://www.w3.org/2001/XMLSchema#string

Cui Li

http://www.w3.org/2001/XMLSchema#string

Guangsen Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Qiong Tan

http://www.w3.org/2001/XMLSchema#string

Jingchen Lu

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Nacef Bahri

http://www.w3.org/2001/XMLSchema#string

Quan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent

Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway

Interleukin-5 and IL-5 receptor in health and diseases

P304

64984-64998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11401

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029406

http://www.w3.org/2001/XMLSchema#string

P932

5630306

http://www.w3.org/2001/XMLSchema#string